Hepatitis B: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
ClaireLewis (talk | contribs) |
||
Line 68: | Line 68: | ||
==See Also== | ==See Also== | ||
*[[ | *[[Viral hepatitis]] | ||
*[[Acute hepatitis]] | *[[Acute hepatitis]] | ||
*[[Jaundice]] | *[[Jaundice]] | ||
==External Links== | ==External Links== | ||
*[[Antibiotics (By_Diagnosis)]] | *[[Antibiotics (By_Diagnosis)]] |
Revision as of 19:53, 8 September 2016
Background
- Blood-borne virus
- Incubation period: 1-3 months
- Virus can cause acute, chronic, or asymptomatic infection
Clinical Features
Differential Diagnosis
Evaluation
- AST, ALT > 1000s
- Elevated bilirubin
- Elevated alk phophatase
- Elevated INR
- Acute hepatitis panel:
Anti-hepatitis A, IgM | Hepatitis B surface antigen | Anti-hepatitis B core, IgM | Anti-hepatitis C | Interpretation |
---|---|---|---|---|
Positive | Negative | Negative | Negative | Acute hepatitis A |
Negative | Positive | Positive | Negative | Acute hepatitis B |
Negative | Positive | Negative | Negative | Chronic hepatitis B infection |
Negative | Negative | Positive | Negative | Acute hepatitis B; quantity of hepatitis B surface antigen is too low to detect |
Negative | Negative | Negative | Positive | Acute or chronic hepatitis C; additional tests are required to make the determination |
Management
- Supportive care for acute disease
Post Exposure Prophylaxis
Hepatitis B Post-Exposure Prophylaxis
Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history[1]
Unvaccinated
- If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites
- If source is HGsAG(-) then start the HBV vaccine series
- If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series
- If source blood is low risk and unavailable then begin HBV series
Previously vaccinated non responder (one series)
Non responder status is defined as anti-has <10mIU/mL
- If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series
- Can also opt to perform second HBIG administration in one month
- If source is HBsAg(-) then no treatment is needed
- If source blood is unavailable and high risk then treat as if HBsAg(+)
Previously vaccinated non responder (two series)
Non responder status is defined as anti-has <10mIU/mL
- If the source is HBsAg(+) then give HBIG x2 and no HBV series
- If source is HGsAG(-) then no treatment is needed
- If source blood is unavailable then initiate the HBV series
Treatment Dosing
No contraindications for pregnancy or breast feeding
- HBIG 0.06 mL/kg IM
- Give in opposite arm from hepatitis B vaccine if patient also receiving vaccine
- Vaccination series: HBV vaccine options:
- Engerix-B 20mcg IM
- Recombivax HB 10mcg IM
Disposition
- Consider admission for:
- INR >2, Bilirubin >30, hypoglycemia
- Any GI bleeding
- Intractable pain, inability to tolerate PO
- Significant comorbidity/immunocompromised or age >50 years
See Also
External Links
References
- ↑ Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e